Annual EBIT
$3.72 M
+$31.86 M+113.20%
December 31, 2023
Summary
- As of February 8, 2025, TCON annual earnings before interest & taxes is $3.72 million, with the most recent change of +$31.86 million (+113.20%) on December 31, 2023.
- During the last 3 years, TCON annual EBIT has risen by +$19.95 million (+122.90%).
- TCON annual EBIT is now at all-time high.
Performance
TCON EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$2.91 M
+$300.00 K+9.34%
June 30, 2024
Summary
- As of February 8, 2025, TCON quarterly earnings before interest & taxes is -$2.91 million, with the most recent change of +$300.00 thousand (+9.34%) on June 30, 2024.
- Over the past year, TCON quarterly EBIT has dropped by -$3.31 million (-824.38%).
- TCON quarterly EBIT is now -125.52% below its all-time high of $11.41 million, reached on September 30, 2023.
Performance
TCON Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
$5.69 M
-$6.51 M-53.37%
June 30, 2024
Summary
- As of February 8, 2025, TCON TTM earnings before interest & taxes is $5.69 million, with the most recent change of -$6.51 million (-53.37%) on June 30, 2024.
- Over the past year, TCON TTM EBIT has dropped by -$2.41 million (-29.74%).
- TCON TTM EBIT is now -53.37% below its all-time high of $12.20 million, reached on March 31, 2024.
Performance
TCON TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
TCON EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +113.2% | -824.4% | -29.7% |
| 3 y3 years | +122.9% | +53.3% | +118.8% |
| 5 y5 years | +110.7% | +53.3% | +125.5% |
TCON EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +113.1% | -125.5% | +69.2% | -53.4% | +117.3% |
| 5 y | 5-year | at high | +113.1% | -125.5% | +69.2% | -53.4% | +117.3% |
| alltime | all time | at high | +110.7% | -125.5% | +73.1% | -53.4% | +116.4% |
TRACON Pharmaceuticals EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2024 | - | -$2.91 M(-9.3%) | $5.69 M(-53.4%) |
| Mar 2024 | - | -$3.21 M(-899.0%) | $12.20 M(+50.7%) |
| Dec 2023 | $3.72 M(-113.2%) | $402.00 K(-96.5%) | $8.09 M(+401.8%) |
| Sep 2023 | - | $11.41 M(+217.3%) | $1.61 M(-110.0%) |
| Jun 2023 | - | $3.60 M(-149.2%) | -$16.17 M(-37.8%) |
| Mar 2023 | - | -$7.31 M(+20.3%) | -$26.01 M(-7.6%) |
| Dec 2022 | -$28.14 M(-0.7%) | -$6.08 M(-4.7%) | -$28.14 M(-5.3%) |
| Sep 2022 | - | -$6.38 M(+2.2%) | -$29.73 M(-1.7%) |
| Jun 2022 | - | -$6.24 M(-34.0%) | -$30.23 M(-7.9%) |
| Mar 2022 | - | -$9.45 M(+23.3%) | -$32.84 M(+15.8%) |
| Dec 2021 | -$28.35 M(+74.7%) | -$7.66 M(+11.3%) | -$28.35 M(+14.0%) |
| Sep 2021 | - | -$6.88 M(-22.2%) | -$24.86 M(+13.9%) |
| Jun 2021 | - | -$8.85 M(+78.6%) | -$21.83 M(+26.2%) |
| Mar 2021 | - | -$4.96 M(+18.6%) | -$17.30 M(+6.6%) |
| Dec 2020 | -$16.23 M(-27.2%) | -$4.18 M(+8.5%) | -$16.23 M(+2.4%) |
| Sep 2020 | - | -$3.85 M(-10.7%) | -$15.86 M(-7.2%) |
| Jun 2020 | - | -$4.31 M(+10.9%) | -$17.08 M(-10.1%) |
| Mar 2020 | - | -$3.89 M(+2.2%) | -$19.01 M(-14.7%) |
| Dec 2019 | -$22.29 M(-35.8%) | -$3.80 M(-25.1%) | -$22.29 M(-15.0%) |
| Sep 2019 | - | -$5.08 M(-18.6%) | -$26.21 M(-13.2%) |
| Jun 2019 | - | -$6.24 M(-12.9%) | -$30.21 M(-10.4%) |
| Mar 2019 | - | -$7.17 M(-7.3%) | -$33.71 M(-2.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2018 | -$34.73 M(+90.6%) | -$7.73 M(-14.8%) | -$34.73 M(+4.1%) |
| Sep 2018 | - | -$9.07 M(-6.8%) | -$33.35 M(+45.7%) |
| Jun 2018 | - | -$9.74 M(+18.9%) | -$22.89 M(+17.5%) |
| Mar 2018 | - | -$8.19 M(+28.9%) | -$19.48 M(+7.0%) |
| Dec 2017 | -$18.22 M(-29.6%) | -$6.36 M(-556.2%) | -$18.21 M(+2.1%) |
| Sep 2017 | - | $1.39 M(-122.0%) | -$17.84 M(-28.1%) |
| Jun 2017 | - | -$6.33 M(-8.5%) | -$24.84 M(-6.3%) |
| Mar 2017 | - | -$6.92 M(+15.6%) | -$26.52 M(+2.4%) |
| Dec 2016 | -$25.89 M(+10.3%) | -$5.99 M(+7.0%) | -$25.89 M(-15.8%) |
| Sep 2016 | - | -$5.60 M(-30.1%) | -$30.74 M(-2.0%) |
| Jun 2016 | - | -$8.01 M(+27.3%) | -$31.38 M(+20.4%) |
| Mar 2016 | - | -$6.29 M(-41.9%) | -$26.06 M(+10.9%) |
| Dec 2015 | -$23.47 M(+279.8%) | -$10.84 M(+73.8%) | -$23.51 M(+57.0%) |
| Sep 2015 | - | -$6.24 M(+131.2%) | -$14.97 M(+43.5%) |
| Jun 2015 | - | -$2.70 M(-27.9%) | -$10.43 M(+21.0%) |
| Mar 2015 | - | -$3.74 M(+62.5%) | -$8.62 M(+39.5%) |
| Dec 2014 | -$6.18 M(-19.5%) | -$2.30 M(+35.8%) | -$6.18 M(+2.0%) |
| Sep 2014 | - | -$1.70 M(+91.3%) | -$6.06 M(+38.8%) |
| Jun 2014 | - | -$886.00 K(-31.7%) | -$4.37 M(+25.5%) |
| Mar 2014 | - | -$1.30 M(-40.6%) | -$3.48 M(+59.4%) |
| Dec 2013 | -$7.68 M(+55.8%) | -$2.18 M | -$2.18 M |
| Dec 2012 | -$4.93 M | - | - |
FAQ
- What is TRACON Pharmaceuticals annual earnings before interest & taxes?
- What is the all time high annual EBIT for TRACON Pharmaceuticals?
- What is TRACON Pharmaceuticals annual EBIT year-on-year change?
- What is TRACON Pharmaceuticals quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for TRACON Pharmaceuticals?
- What is TRACON Pharmaceuticals quarterly EBIT year-on-year change?
- What is TRACON Pharmaceuticals TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for TRACON Pharmaceuticals?
- What is TRACON Pharmaceuticals TTM EBIT year-on-year change?
What is TRACON Pharmaceuticals annual earnings before interest & taxes?
The current annual EBIT of TCON is $3.72 M
What is the all time high annual EBIT for TRACON Pharmaceuticals?
TRACON Pharmaceuticals all-time high annual earnings before interest & taxes is $3.72 M
What is TRACON Pharmaceuticals annual EBIT year-on-year change?
Over the past year, TCON annual earnings before interest & taxes has changed by +$31.86 M (+113.20%)
What is TRACON Pharmaceuticals quarterly earnings before interest & taxes?
The current quarterly EBIT of TCON is -$2.91 M
What is the all time high quarterly EBIT for TRACON Pharmaceuticals?
TRACON Pharmaceuticals all-time high quarterly earnings before interest & taxes is $11.41 M
What is TRACON Pharmaceuticals quarterly EBIT year-on-year change?
Over the past year, TCON quarterly earnings before interest & taxes has changed by -$3.31 M (-824.38%)
What is TRACON Pharmaceuticals TTM earnings before interest & taxes?
The current TTM EBIT of TCON is $5.69 M
What is the all time high TTM EBIT for TRACON Pharmaceuticals?
TRACON Pharmaceuticals all-time high TTM earnings before interest & taxes is $12.20 M
What is TRACON Pharmaceuticals TTM EBIT year-on-year change?
Over the past year, TCON TTM earnings before interest & taxes has changed by -$2.41 M (-29.74%)